Evidence map›Paper›PMID 41487911›Full record

ArticleInternational journal of biological sciences2025

Erratum: Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination: Erratum.

Xiaofeng Dai, Dongyan Cai, Peiyu Wang, Nan Nan, Lihui Yu, Zhifa Zhang, Renwu Zhou, Dong Hua, Jianying Zhang, Kostya Ken Ostrikov and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xiaofeng DaiWuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Dongyan CaiAffiliated Hospital of Jiangnan University, Wuxi 214122, China.
Peiyu WangInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane 4059, Australia.
Nan NanWuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Lihui YuWuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Zhifa ZhangWuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Renwu ZhouSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia.
Dong HuaWuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Jianying ZhangBGI College & Henan Institute of Medical and Pharmaceutical Sciences in Academy of Medical Science, Zhengzhou University, 450052, China.
Kostya Ken OstrikovTranslational Research Institute, Woolloongabba, Queensland 4102, Australia.
Erik ThompsonTranslational Research Institute, Woolloongabba, Queensland 4102, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.7150/ijbs.72296.].

Identifiers

PMID41487911
PMCPMC12757133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.